Cargando…
Identification of prognostic and immunotherapy-related eRNA ID2-AS1 in bladder cancer
AbstractEnhancer RNAs (eRNAs) can participate in enhancer regulation and target gene transcription, thus affecting the occurrence and development of tumors. In this study, we identified eRNAs closely related to bladder cancer (BLCA). Gene expression profiles and clinical information from The Cancer...
Autores principales: | Zhang, Lei, Ding, Degang, Liu, Jianjun, Liu, Junfeng, Wang, Ning, Liu, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239636/ https://www.ncbi.nlm.nih.gov/pubmed/35776987 http://dx.doi.org/10.1097/MD.0000000000029759 |
Ejemplares similares
-
Identification and Validation of an Immune-Related eRNA Prognostic Signature for Hepatocellular Carcinoma
por: Cai, Shenglan, et al.
Publicado: (2021) -
Exploring the potential of eRNAs in cancer immunotherapy
por: Luo, Lianxiang, et al.
Publicado: (2022) -
Enhancer RNA (eRNA) in Human Diseases
por: Wang, Yunzhe, et al.
Publicado: (2022) -
Evaluate the immune-related eRNA models and signature score to predict the response to immunotherapy in thyroid carcinoma
por: Wu, Pu, et al.
Publicado: (2022) -
The integrated landscape of eRNA in gastric cancer reveals distinct immune subtypes with prognostic and therapeutic relevance
por: Hu, Xin, et al.
Publicado: (2022)